| scholarly article | Q13442814 |
| P50 | author | Gerald J. Holtmann | Q37834742 |
| P2093 | author name string | Liebregts T | |
| Vinson B | |||
| Adam B | |||
| Saadat-Gilani K | |||
| P2860 | cites work | Meta-analysis: phytotherapy of functional dyspepsia with the herbal drug preparation STW 5 (Iberogast). | Q34377528 |
| A randomised clinical trial comparing the efficacy of a herbal preparation STW 5 with the prokinetic drug cisapride in patients with dysmotility type of functional dyspepsia | Q34523878 | ||
| Increased prevalence of irritable bowel syndrome in patients with gastroesophageal reflux | Q34548906 | ||
| Treatment of functional dyspepsia with a herbal preparation. A double-blind, randomized, placebo-controlled, multicenter trial | Q39384718 | ||
| Development of a new dyspepsia impact scale: the Nepean Dyspepsia Index | Q48768618 | ||
| Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia. | Q51035370 | ||
| Delayed gastric emptying in gastroesophageal reflux disease: reassessment with new methods and symptomatic correlations. | Q51722641 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | patient | Q181600 |
| P304 | page(s) | 357-363 | |
| P577 | publication date | 2005-08-01 | |
| P1433 | published in | Alimentary Pharmacology & Therapeutics | Q4726656 |
| P1476 | title | Validation of the gastrointestinal symptom score for the assessment of symptoms in patients with functional dyspepsia. | |
| P478 | volume | 22 |
| Q33845395 | 'Gut health': a new objective in medicine? |
| Q47148113 | A non-interventional, observational study of a fixed combination of pepsin and amino acid hydrochloride in patients with functional dyspepsia. |
| Q37581131 | Acupuncture for Functional Dyspepsia: What Strength Does It Have? A Systematic Review and Meta-Analysis of Randomized Controlled Trials |
| Q92341745 | Altered Functional Connectivity of the Amygdala and Sex Differences in Functional Dyspepsia |
| Q42775457 | An Extract of Glycyrrhiza glabra (GutGard) Alleviates Symptoms of Functional Dyspepsia: A Randomized, Double-Blind, Placebo-Controlled Study |
| Q61812165 | Appetite Perceptions, Gastrointestinal Symptoms, Ghrelin, Peptide YY and State Anxiety Are Disturbed in Adolescent Females with Anorexia Nervosa and Only Partially Restored with Short-Term Refeeding |
| Q57789445 | Association between clinical manifestations of complicated and uncomplicated peptic ulcer and visceral sensory dysfunction |
| Q34067691 | Banha-sasim-tang as an herbal formula for the treatment of functional dyspepsia: a randomized, double-blind, placebo-controlled, two-center trial |
| Q49474909 | Complementary and alternative treatment in functional dyspepsia |
| Q37253647 | Development of a Symptom-Based Patient-Reported Outcome Instrument for Functional Dyspepsia: A Preliminary Conceptual Model and an Evaluation of the Adequacy of Existing Instruments. |
| Q34764154 | Development of an online library of patient-reported outcome measures in gastroenterology: the GI-PRO database. |
| Q39152285 | Early onset of efficacy in patients with functional and motility-related gastrointestinal disorders : A noninterventional study with Iberogast®. |
| Q39904311 | Endoscopic and Histological Findings Are Predicted by Fecal Calprotectin in Acute Intestinal Graft-Versus-Host-Disease |
| Q80533122 | How safe and effective is the herbal drug STW 5 for patients with functional dyspepsia? |
| Q39974210 | Minimum clinically important difference for the Nepean Dyspepsia Index, a validated quality of life scale for functional dyspepsia |
| Q33617439 | Modulation of gastrointestinal motility beyond metoclopramide and domperidone : Pharmacological and clinical evidence for phytotherapy in functional gastrointestinal disorders |
| Q91670693 | Network-Based Selection of Candidate Markers and Assays to Assess the Impact of Oral Immune Interventions on Gut Functions |
| Q36817391 | Patient-reported outcomes in gastroenterology: clinical and research applications |
| Q36997052 | Prevalence of Small Intestinal Bacterial Overgrowth among Chronic Pancreatitis Patients: A Case-Control Study |
| Q37827564 | Review article: endpoints used in functional dyspepsia drug therapy trials |
| Q38069486 | STW 5 (Iberogast®)--a safe and effective standard in the treatment of functional gastrointestinal disorders |
| Q54250888 | Small bowel homing T cells are associated with symptoms and delayed gastric emptying in functional dyspepsia. |
| Q90647558 | Sodium citrate ingestion protocol impacts induced alkalosis, gastrointestinal symptoms, and palatability |
| Q34654360 | The Effects of Banha-sasim-tang on Dyspeptic Symptoms and Gastric Motility in Cases of Functional Dyspepsia: A Randomized, Double-Blind, Placebo-Controlled, and Two-Center Trial |
| Q30488670 | The Gastrointestinal Pain Pointer: A Valid and Innovative Method to Assess Gastrointestinal Symptoms |
| Q43362951 | The Validity of a New Structured Assessment of Gastrointestinal Symptoms Scale (SAGIS) for Evaluating Symptoms in the Clinical Setting. |
| Q94340226 | UEG Week 2016 Poster Presentations |
Search more.